Email not displaying properly? View email in your browser
Vertical-Talk Pharma    Metal-Organic Framework
 Gene Therapy
 Digital Pill
Dec 2017 e-Newsletter Archives    |    Advertise
Follow Us Facebook Twitter Google Plus Linkedin
 Turkish Cargo
News
Teva Announces Exclusive Launch of Generic...
Novartis multiple sclerosis therapy fingolimod...
Confo Therapeutics Enters Into Drug Discovery...
 
Press Releases
Evox Therapeutics to Collaborate with...
Biogen and Ionis Enter into New Collaboration...
New Precision Balances Speed Up Lab Processes...
 
Events
11 -13 Jan 2018
1st Emirates Family Medicine Society...
16 -18 Jan 2018
7th Trial Master File Summit
18 -18 Jan 2018
PHARMACONNECT 2018
Articles
  Nanocomposite Hybrid Metal-Organic Framework in Drug Delivery...
Md. Habban Akhter, Assistant Professor, DIT University, India
Metal-Organic Framework (MOF) comprises of metal ion coupled with organic ligands i.e., polymer-metal nanocomposite, which are a recent advances in chemistry for drug delivery and biomedical application. The MOF is porous structure at nanoscale, uses an innovative biomaterial which has compatible physicochemical properties in the biological system. They are being widely explored worldwide nowadays for potential...
Techno Trends
 First-of-its Kind Gene Therapy Could Treat Inherited Blindness
 First Digital Pill Tracks Patients Medication
Emirates Skycargo
Projects
 Kaneka Eurogentec to Build Manufacturing Facility in Belgium
 Merck MilliporeSigma Opens its First BioReliance® End-to-End...
Reports
 Singapore Pharmaceutical Market: Full of Opportunities for Global...
FPS
e-Magazine  |  Subscribe  |  Unsubscribe  |  Previous Issues  |  Advisory Board  |  Editorial Calendar  |  Media Pack
www.pharmafocusasia.com – Owned by Ochre Media Pvt. Ltd.
Media Resource Centre, 2nd Floor, Oxford Plaza, Secunderabad - 500 003, Telangana, India
Tel: +91 40 4961 4567 I Fax: +91 40 4961 4555